An early robotic congenital series
Bacha coauthored a programme report of 26 selected children and adults treated during 2023–2025, most with ASD or anomalous pulmonary venous return. It reports early feasibility, with pleural effusions and pericarditis among complications.
How to interpret this: Uncontrolled early experience, not proof that robotic repair is better. Coauthorship does not establish who operated on each patient.
Sources: Early outcomes of a formal robotic congenital cardiac surgery program.
